臨床試驗

qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver

NCT：NCT06971991 · RECRUITING

NCT IDNCT06971991

狀態RECRUITING

開始日期2025-03-13

SponsorUniversity of Wisconsin, Madison (OTHER)

First posted2025-05-14

Last updated2026-09-15

簡要摘要

The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver embolization is a way of treating liver tumors by blocking blood flow to it. The qDSA technique could help doctors ensure the blood flow to the tumor is decreased by the right amount by calculating blood flow before, during, and after the procedure. Up to 20 participants will be enrolled for 1 study visit and data collection for up to 6 months.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。